348 related articles for article (PubMed ID: 23625360)
21. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
Sund KK; Skeie GO; Gilhus NE; Aarli JA; Varhaug JE
Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4212-4. PubMed ID: 9441462
[TBL] [Abstract][Full Text] [Related]
22. [Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].
Ito T; Ishizumi T; Kataba H; Saijo T; Ikeda N
Kyobu Geka; 2018 Aug; 71(8):634-636. PubMed ID: 30185764
[TBL] [Abstract][Full Text] [Related]
23. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L
J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149
[TBL] [Abstract][Full Text] [Related]
24. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
Penn AS; Schotland DL; Lamme S
Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
[TBL] [Abstract][Full Text] [Related]
25. Striational antibodies in a paraneoplastic context.
McKeon A; Lennon VA; LaChance DH; Klein CJ; Pittock SJ
Muscle Nerve; 2013 Apr; 47(4):585-7. PubMed ID: 23463255
[TBL] [Abstract][Full Text] [Related]
26. Acetylcholine receptor antibodies in myasthenia gravis.
Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
[TBL] [Abstract][Full Text] [Related]
27. The Duke myasthenia gravis clinic registry: I. Description and demographics.
Sanders DB; Raja SM; Guptill JT; Hobson-Webb LD; Juel VC; Massey JM
Muscle Nerve; 2021 Feb; 63(2):209-216. PubMed ID: 33205437
[TBL] [Abstract][Full Text] [Related]
28. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
Williams CL; Hay JE; Huiatt TW; Lennon VA
Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
[TBL] [Abstract][Full Text] [Related]
29. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
Buckley C; Newsom-Davis J; Willcox N; Vincent A
Neurology; 2001 Nov; 57(9):1579-82. PubMed ID: 11706095
[TBL] [Abstract][Full Text] [Related]
30. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.
Tsinzerling N; Lefvert AK; Matell G; Pirskanen-Matell R
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1109-12. PubMed ID: 17353257
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
[TBL] [Abstract][Full Text] [Related]
33. Acetylcholine receptor epitope in proteins of myasthenia gravis-associated thymomas and non-thymic tissues.
Marx A; O'Connor R; Tzartos S; Kalies I; Kirchner T; Müller-Hermelink HK
Thymus; 1989; 14(1-3):171-8. PubMed ID: 2482999
[TBL] [Abstract][Full Text] [Related]
34. Myasthenia gravis with autoimmune autonomic neuropathy.
Vernino S; Cheshire WP; Lennon VA
Auton Neurosci; 2001 May; 88(3):187-92. PubMed ID: 11474561
[TBL] [Abstract][Full Text] [Related]
35. Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.
Massa R; Greco G; Testi M; Rastelli E; Terracciano C; Frezza E; Garibaldi M; Marfia GA; Locatelli F; Mercuri NB; Pompeo E; Antonini G; Andreani M
J Neurol; 2019 Apr; 266(4):982-989. PubMed ID: 30741378
[TBL] [Abstract][Full Text] [Related]
36. The diagnosis of thymoma in myasthenia gravis.
Aarli JA
Ital J Neurol Sci; 1983 Dec; 4(4):393-7. PubMed ID: 6370907
[TBL] [Abstract][Full Text] [Related]
37. Acetylcholine receptor epitopes on epithelial cells of thymoma in myasthenia gravis.
Kirchner T; Hoppe F; Müller-Hermelink HK; Schalke B; Tzartos S
Lancet; 1987 Jan; 1(8526):218. PubMed ID: 2433555
[No Abstract] [Full Text] [Related]
38. Myasthenia gravis in individuals over 40.
Aarli JA; Romi F; Skeie GO; Gilhus NE
Ann N Y Acad Sci; 2003 Sep; 998():424-31. PubMed ID: 14592910
[TBL] [Abstract][Full Text] [Related]
39. Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
Shelly S; Paul P; Bi H; Dubey D; Milone M; Sorenson EJ; Crum BA; Laughlin RS; Liewluck T; Mandrekar J; Pittock SJ; Zekeridou A; McKeon A; Harper MC; Mills JR; Klein CJ
Neurology; 2020 Dec; 95(22):e3002-e3011. PubMed ID: 32938782
[TBL] [Abstract][Full Text] [Related]
40. Myasthenia gravis: predictive factors associated with the synchronized elevation of anti-acetylcholine receptor antibody titer in Kanazawa, Japan.
Iwasa K; Yoshikawa H; Samuraki M; Shinohara M; Hamaguchi T; Ono K; Nakamura H; Yamada M
J Neuroimmunol; 2014 Feb; 267(1-2):97-101. PubMed ID: 24388223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
